Andrews Patricia S
- SEC CIK
- 0001445710
In the past year, 1 open-market purchase filing worth $30.4K and no sales.
Current role at each company
- ONCY Oncolytics Biotech IncDirectoras of Jun 3, 2026
- GERN Geron CorpDirectoras of Mar 26, 2026
- CBIO Crescent Biopharma, Inc.Directoras of May 1, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $30.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$30.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Andrews Patricia S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ONCY Oncolytics Biotech Inc
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2026 (view filing) | Feb 12 | 1 day | Andrews Patricia SDirector | PPurchase | +35.4K | $0.86 | +$30.4K | +82.8%78.1K after |
CBIO Crescent Biopharma, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2021 (view filing) | Nov 16 | 2 days | Andrews Patricia SDirector | PPurchase | +40.0K | $2.05 | +$82.0K | +761.9%45.3K after |